210 related articles for article (PubMed ID: 29386013)
1. Effect of neoadjuvant chemotherapy and its correlation with HPV status, EGFR, Her-2-neu, and GADD45 expression in oral squamous cell carcinoma.
Pandey M; Kannepali KK; Dixit R; Kumar M
World J Surg Oncol; 2018 Jan; 16(1):20. PubMed ID: 29386013
[TBL] [Abstract][Full Text] [Related]
2. Role of human papilloma virus in oral tongue squamous cell carcinoma.
Elango KJ; Suresh A; Erode EM; Subhadradevi L; Ravindran HK; Iyer SK; Iyer SK; Kuriakose MA
Asian Pac J Cancer Prev; 2011; 12(4):889-96. PubMed ID: 21790221
[TBL] [Abstract][Full Text] [Related]
3. Prognosis of esophageal squamous cell carcinoma in patients positive for human epidermal growth factor receptor family can be improved by initial chemotherapy with docetaxel, fluorouracil, and cisplatin.
Yamamoto Y; Yamai H; Seike J; Yoshida T; Takechi H; Furukita Y; Kajiura K; Minato T; Bando Y; Tangoku A
Ann Surg Oncol; 2012 Mar; 19(3):757-65. PubMed ID: 21947696
[TBL] [Abstract][Full Text] [Related]
4. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.
Fakhry C; Westra WH; Li S; Cmelak A; Ridge JA; Pinto H; Forastiere A; Gillison ML
J Natl Cancer Inst; 2008 Feb; 100(4):261-9. PubMed ID: 18270337
[TBL] [Abstract][Full Text] [Related]
5. Combination of EGFR, HER-2/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members.
Xia W; Lau YK; Zhang HZ; Xiao FY; Johnston DA; Liu AR; Li L; Katz RL; Hung MC
Clin Cancer Res; 1999 Dec; 5(12):4164-74. PubMed ID: 10632356
[TBL] [Abstract][Full Text] [Related]
6. Impact of epidermal growth factor receptor, mesenchymal-epithelial transition factor, and insulin-like growth factor receptor 1 expression on survival of patients with oral and oropharyngeal cancer.
Perisanidis C; Wrba F; Brandstetter A; Kornek G; Mitchell D; Seemann R; Selzer E; Ewers R; Filipits M
Br J Oral Maxillofac Surg; 2013 Apr; 51(3):234-40. PubMed ID: 22889668
[TBL] [Abstract][Full Text] [Related]
7. Multidisciplinary approach in advanced cancer of the oral cavity: outcome with neoadjuvant chemotherapy according to intention-to-treat local therapy. A phase II study.
Grau JJ; Domingo J; Blanch JL; Verger E; Castro V; Nadal A; Alós L; Estapé J
Oncology; 2002; 63(4):338-45. PubMed ID: 12417788
[TBL] [Abstract][Full Text] [Related]
8. HER-2/neu expression as a predictor of response to neoadjuvant docetaxel in patients with operable breast carcinoma.
Learn PA; Yeh IT; McNutt M; Chisholm GB; Pollock BH; Rousseau DL; Sharkey FE; Cruz AB; Kahlenberg MS
Cancer; 2005 Jun; 103(11):2252-60. PubMed ID: 15834928
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of p16 expression, HPV infection and its prognostic utility in oral squamous cell carcinoma.
Gröbe A; Hanken H; Kluwe L; Schöllchen M; Tribius S; Pohlenz P; Clauditz T; Grob T; Simon R; Sauter G; Heiland M; Blessmann M
J Oral Pathol Med; 2013 Oct; 42(9):676-81. PubMed ID: 23721566
[TBL] [Abstract][Full Text] [Related]
10. Control of cell proliferation kinetics of tumor in neoadjuvant chemotherapy for advanced oral squamous cell carcinoma and its prognostic implications.
Noguchi M; Kinjyo H; Miyazaki A; Kubota H; Kohama G
Int J Clin Oncol; 2002 Jun; 7(3):138-44. PubMed ID: 12109514
[TBL] [Abstract][Full Text] [Related]
11. Sequential therapy of advanced buccal mucosa squamous cell carcinoma: three-year outcome.
Lyu J; Li C; Wu Y; Wang R; Ren G; Guo W
J Oral Maxillofac Surg; 2014 Mar; 72(3):606-10. PubMed ID: 24342583
[TBL] [Abstract][Full Text] [Related]
12. The predictive value of EGFR and HER-2/neu in tumor tissue and serum for response to anthracycline-based neoadjuvant chemotherapy of breast cancer.
Schippinger W; Dandachi N; Regitnig P; Hofmann G; Balic M; Neumann R; Samonigg H; Bauernhofer T
Am J Clin Pathol; 2007 Oct; 128(4):630-7. PubMed ID: 17875515
[TBL] [Abstract][Full Text] [Related]
13. Four-protein signature accurately predicts lymph node metastasis and survival in oral squamous cell carcinoma.
Zanaruddin SN; Saleh A; Yang YH; Hamid S; Mustafa WM; Khairul Bariah AA; Zain RB; Lau SH; Cheong SC
Hum Pathol; 2013 Mar; 44(3):417-26. PubMed ID: 23026198
[TBL] [Abstract][Full Text] [Related]
14. Human Papillomavirus and Epidermal Growth Factor Receptor in Oral Cavity and Oropharyngeal Squamous Cell Carcinoma: Correlation With Dynamic Contrast-Enhanced MRI Parameters.
Choi YS; Park M; Kwon HJ; Koh YW; Lee SK; Kim J
AJR Am J Roentgenol; 2016 Feb; 206(2):408-13. PubMed ID: 26797372
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor expression correlates with poor survival in patients who have breast carcinoma treated with doxorubicin-based neoadjuvant chemotherapy.
Buchholz TA; Tu X; Ang KK; Esteva FJ; Kuerer HM; Pusztai L; Cristofanilli M; Singletary SE; Hortobagyi GN; Sahin AA
Cancer; 2005 Aug; 104(4):676-81. PubMed ID: 15981280
[TBL] [Abstract][Full Text] [Related]
16. 5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial.
Gianni L; Pienkowski T; Im YH; Tseng LM; Liu MC; Lluch A; Starosławska E; de la Haba-Rodriguez J; Im SA; Pedrini JL; Poirier B; Morandi P; Semiglazov V; Srimuninnimit V; Bianchi GV; Magazzù D; McNally V; Douthwaite H; Ross G; Valagussa P
Lancet Oncol; 2016 Jun; 17(6):791-800. PubMed ID: 27179402
[TBL] [Abstract][Full Text] [Related]
17. [Phase II clinical trial of neoadjuvant therapy with carboplatin plus paclitaxel for locally advanced triple-negative breast cancer].
Ma WY; Zhang P; Zhang BL; Wang X; Xu XZ; Zheng S; Wang JY; Cai RG; Yuan P; Ma F; Fan Y; Xu BH
Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):770-4. PubMed ID: 23291072
[TBL] [Abstract][Full Text] [Related]
18. Prognostic features, human papillomavirus status, and epidermal growth factor receptor expression in oral squamous cell carcinoma in young adults.
Thomas L; Moore EJ; McGree ME; Olsen KD; Kasperbauer JL; Erickson LA; Schembri-Wismayer DJ
Am J Otolaryngol; 2012; 33(6):650-6. PubMed ID: 22387125
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapeutic alteration of VEGF-/PDGF- and PDGF-Rα/β expression by imatinib in HPV-transformed squamous cell carcinoma compared to HPV-negative HNSCC in vitro.
Schultz JD; Mühlheim K; Erben P; Hofheinz RD; Faber A; Thorn C; Sommer JU; Hörmann K; Sauter A
Oncol Rep; 2011 Nov; 26(5):1099-109. PubMed ID: 21805039
[TBL] [Abstract][Full Text] [Related]
20. Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer.
Reimers N; Kasper HU; Weissenborn SJ; Stützer H; Preuss SF; Hoffmann TK; Speel EJ; Dienes HP; Pfister HJ; Guntinas-Lichius O; Klussmann JP
Int J Cancer; 2007 Apr; 120(8):1731-8. PubMed ID: 17236202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
